Drug name - Tyvaso

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9604901 UNITED THERAP Process to prepare treprostinil, the active ingredient in Remodulin®
Dec, 2028

(6 years from now)

US9593066 UNITED THERAP Process to prepare treprostinil, the active ingredient in remodulin®
Dec, 2028

(6 years from now)

CN103274926A UNITED THERAP Process To Prepare Treprostinil, The Active Ingredient In Remodulin
Dec, 2028

(6 years from now)

CN101903324B UNITED THERAP A Kind Of Preparation Of Active Composition In Remodulin Curved Latanoprost Is Improved Method
Dec, 2028

(6 years from now)

CN101903324A UNITED THERAP An Improved Process To Prepare Treprostinil, The Active Ingredient In Remodulin
Dec, 2028

(6 years from now)

CN103274926B UNITED THERAP An Improved Method For Preparing Active Components In The Curved Remodulin
Dec, 2028

(6 years from now)

IN201003640P4 UNITED THERAP An Improved Process To Prepare Treprostinil,The Active Ingredient In Remodulin
Dec, 2028

(6 years from now)

IN287697B UNITED THERAP An Improved Process To Prepare Treprostinil, The Active Ingredient In Remodulin
Dec, 2028

(6 years from now)

EP2252570A1 UNITED THERAP An Improved Process To Prepare Treprostinil, The Active Ingredient In Remodulin ®
Dec, 2028

(6 years from now)

EP2252570B1 UNITED THERAP An Improved Process To Prepare Treprostinil, The Active Ingredient In Remodulin ®
Dec, 2028

(6 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10716793 UNITED THERAP Treprostinil administration by inhalation May, 2027

(4 years from now)

US10376525 UNITED THERAP Treprostinil administration by inhalation May, 2027

(4 years from now)

US9339507 UNITED THERAP Treprostinil administration by inhalation Mar, 2028

(5 years from now)

US9358240 UNITED THERAP Treprostinil administration by inhalation May, 2028

(5 years from now)

Drugs and Companies using TREPROSTINIL ingredient

Treatment: Method of treating pulmonary hypertension by administering treprostinil or a salt thereof by inhalation using a device

Dosage: SOLUTION;INHALATION

More Information on Dosage
Strength Dosage Availability
0.6MG/ML SOLUTION;INHALATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.